BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30414069)

  • 1. Induced Pluripotent Stem Cells in Disease Modelling and Regeneration.
    Talug B; Tokcaer-Keskin Z
    Adv Exp Med Biol; 2019; 1144():91-99. PubMed ID: 30414069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development course and an application strategy for induced pluripotent stem cells in regenerative medicine.
    Xu Y; Wang J; Mao R; Tang X; Huang R; Wang R; Lin Y
    Curr Stem Cell Res Ther; 2014 May; 9(3):244-53. PubMed ID: 24524789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
    Hu C; Li L
    Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
    Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y
    J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promise of induced pluripotent stem cells in research and therapy.
    Robinton DA; Daley GQ
    Nature; 2012 Jan; 481(7381):295-305. PubMed ID: 22258608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The triumph of chemically enhanced cellular reprogramming: a patent review.
    Anwar MA; Kim S; Choi S
    Expert Opin Ther Pat; 2016; 26(2):265-80. PubMed ID: 26593376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of biomaterials to advance induced pluripotent stem cell research and therapy.
    Tong Z; Solanki A; Hamilos A; Levy O; Wen K; Yin X; Karp JM
    EMBO J; 2015 Apr; 34(8):987-1008. PubMed ID: 25766254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial (Thematic Issue: Current Status of Stem Cell Research in Regenerative Medicine - How Close We Are from Bench Side to Bedside?).
    Feng YM
    Curr Stem Cell Res Ther; 2016; 11(7):532. PubMed ID: 27640916
    [No Abstract]   [Full Text] [Related]  

  • 12. [Breakthrough in research on pluripotent stem cells and their application in medicine].
    Valdimarsdóttir G; Richter A
    Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Application of Induced Pluripotent Stem Cells in Cardiovascular Medicine.
    Chi HJ; Gao S; Yang XC; Cai J; Zhao WS; Sun H; Geng YJ
    Cardiology; 2015; 131(4):236-44. PubMed ID: 25969168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [iPS cells for the generation of cartilage and for regenerative medicine and disease modeling of cartilage diseases].
    Tsumaki N
    Clin Calcium; 2016 Apr; 26(4):587-92. PubMed ID: 27013630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induced pluripotent stem cells: a new paradigm to study human tissues].
    Sansac C; Assou S; Bouckenheimer J; Lemaître JM; De Vos J
    Biol Aujourdhui; 2016; 210(1):1-8. PubMed ID: 27286575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPS cell technologies and cartilage regeneration.
    Tsumaki N; Okada M; Yamashita A
    Bone; 2015 Jan; 70():48-54. PubMed ID: 25026496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.
    Csöbönyeiová M; Polák Š; Danišovič L
    Exp Biol Med (Maywood); 2015 May; 240(5):549-56. PubMed ID: 25595188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.